Loading company…
Tusk Therapeutics is a UK biotech developing immunotherapies for serious diseases, including cancer.
Tusk Therapeutics Ltd researches and develops novel immunotherapies, with a pipeline aimed at cancer and other serious conditions. Founded in 2015 and headquartered in the UK, the company completed a trade sale in September 2018 for EUR 70.00 mn. It reported zero revenue and zero EBITDA in 2016.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in